Metraipolis › archive › dc_4fd1035800fd

A Randomized Phase 3 Study to Evaluate the Safety, Tolerability, and Immunogenicity of the Bivalent RSVpreF Vaccine in Older Adults in Korea — Europe PMC PMID:42797593

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42797593
DOI
10.3390/vaccines14090773
License (as archived)
solo-consultazione
Archived
2026-10-16T05:39:54.921Z
SHA-256 of the archived text
95d9cec9258fbd41623ec491848641ab6b3a54a18214f1bba60bd8c3ceeb2a7f
Stable URL of this page
https://metraipolis.com/documento/dc_4fd1035800fd

How to cite

A Randomized Phase 3 Study to Evaluate the Safety, Tolerability, and Immunogenicity of the Bivalent RSVpreF Vaccine in Older Adults in Korea — Europe PMC PMID:42797593 — Europe PMC (en), https://europepmc.org/article/MED/42797593 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_4fd1035800fd (Metraipolis archive dc_4fd1035800fd, sha256 95d9cec9258fbd41623ec491848641ab6b3a54a18214f1bba60bd8c3ceeb2a7f)
BibTeX
@misc{dc4fd1035800fd,
  title = {A Randomized Phase 3 Study to Evaluate the Safety, Tolerability, and Immunogenicity of the Bivalent RSVpreF Vaccine in Older Adults in Korea — Europe PMC PMID:42797593},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42797593},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_4fd1035800fd; sha256 95d9cec9258fbd41623ec491848641ab6b3a54a18214f1bba60bd8c3ceeb2a7f},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42797593. Agents can read the archived copy with the MCP tool read_document.